Literature DB >> 27133486

Patient-Reported Outcomes in Rheumatoid Arthritis.

Lilian H D van Tuyl1, Kaleb Michaud2.   

Abstract

Patient-reported outcomes (PROs) and their measures have a long and important history for determining the status and treatment of patients with rheumatoid arthritis (RA). This article describes the history and evolution of PROs for RA and the current state of the field, with key examples of accepted and widely used measures, and offers some reflection on the roles of PROs for the study and management of RA.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health domains; Patient-reported outcomes; Questionnaires; Rheumatoid arthritis

Mesh：

Year:  2016        PMID： 27133486     DOI： 10.1016/j.rdc.2016.01.010

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  8 in total

1.  Responsiveness of Patient-Reported Outcomes Measurement Information System Measures in Rheumatoid Arthritis Patients Starting or Switching a Disease-Modifying Antirheumatic Drug.

Authors:  Alyssa Wohlfahrt; Clifton O Bingham; Wendy Marder; Kristine Phillips; Marcy B Bolster; Larry W Moreland; Zhi Zhang; Tuhina Neogi; Yvonne C Lee
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04       Impact factor: 4.794

Review 2.  Selecting patient-reported outcome measures of health-related quality of life in adult rheumatology: quality and breadth of coverage.

Authors:  Erin Knight; Karen E Schifferdecker; Guy S Eakin; Bryce B Reeve
Journal:  Rheumatol Int       Date:  2022-09-20       Impact factor: 3.580

3.  Association of age with the non-achievement of clinical and functional remission in rheumatoid arthritis.

Authors:  Tadashi Aoki; Hideki Ito; Takehisa Ogura; Ayako Hirata; Yuji Nishiwaki; Hideto Kameda
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

4.  Young people's perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force.

Authors:  Erika Mosor; Paul Studenic; Alessia Alunno; Ivan Padjen; Wendy Olsder; Sofia Ramiro; Ilaria Bini; Nele Caeyers; Laure Gossec; Marios Kouloumas; Elena Nikiphorou; Simon Stones; Tanita-Christina Wilhelmer; Tanja A Stamm
Journal:  RMD Open       Date:  2021-01

5.  Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.

Authors:  Michel Chevallard; Laura Belloli; Nicola Ughi; Antonella Adinolfi; Cinzia Casu; Maria Di Cicco; Davide Antonio Filippini; Marina Muscarà; Emanuela Schito; Elisa Verduci; Maria Giovanna Gentile; Bartolomeo Di Rosa; Laura Zoppini; Cristina Carli; Chiara Destefani; Angela Luisi; Emanuela Marta Vincenti; Oscar Massimiliano Epis
Journal:  Rheumatol Int       Date:  2021-05-04       Impact factor: 3.580

6.  Physical and Emotional Burden of Rheumatoid Arthritis in Saudi Arabia: An Exploratory Cross-Sectional Study.

Authors:  Mohammed A Omair; Alper Erdogan; Nicole Tietz; Rieke Alten
Journal:  Open Access Rheumatol       Date:  2020-12-24

7.  EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures.

Authors:  Paul Studenic; Tanja A Stamm; Erika Mosor; Ilaria Bini; Nele Caeyers; Laure Gossec; Marios Kouloumas; Elena Nikiphorou; Wendy Olsder; Ivan Padjen; Sofia Ramiro; Simon Stones; Tanita-Christina Wilhelmer; Alessia Alunno
Journal:  RMD Open       Date:  2022-07

8.  What do patients prefer? A multinational, longitudinal, qualitative study on patient-preferred treatment outcomes in early rheumatoid arthritis.

Authors:  Kristien Van der Elst; Elke G E Mathijssen; Ellen Landgren; Ann Bremander; An De Groef; Elisabet Lindqvist; Maria Nylander; Alma Peters; Frank Van den Hoogen; Yvonne van Eijk-Hustings; Gerard Verhoeven; Johanna E Vriezekolk; Rene Westhovens; Ingrid Larsson
Journal:  RMD Open       Date:  2020-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.